• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Other Chemical Reagents Derivatization Reagents
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to 3-Dimethylaminophenylboronic Acid, Hydrochloride (CAS No: 1256355-23-3)

3-Dimethylaminophenylboronic acid, hydrochloride, identified by the Chemical Abstracts Service Number (CAS No) 1256355-23-3, is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound, featuring a boronic acid functional group attached to a dimethylamino-substituted phenyl ring, exhibits unique chemical properties that make it a valuable intermediate in synthetic applications and a promising candidate for various biomedical research endeavors.

The structure of 3-Dimethylaminophenylboronic acid, hydrochloride consists of a phenyl ring substituted with two methyl groups on the nitrogen atom and a boronic acid moiety at the para position relative to the dimethylamino group. This particular arrangement imparts distinct reactivity and solubility characteristics, which are exploited in multiple industrial and research applications. The hydrochloride salt form enhances its solubility in aqueous systems, making it more amenable for use in solution-based reactions and formulations.

In recent years, boronic acids have emerged as pivotal compounds in medicinal chemistry due to their ability to form stable complexes with diols and other polyhydroxy compounds. This property is particularly relevant in the context of glycosylation reactions, where 3-Dimethylaminophenylboronic acid, hydrochloride serves as an effective catalyst or intermediate. The dimethylamino group further influences the electronic environment of the boronic acid, potentially enhancing its affinity for specific biological targets.

One of the most notable applications of 3-Dimethylaminophenylboronic acid, hydrochloride is in the development of targeted drug delivery systems. Boron-containing compounds have been extensively studied for their potential use in boron neutron capture therapy (BNCT), a novel approach to cancer treatment that leverages the selective accumulation of boron compounds in tumor tissues. The unique structural features of this compound make it an attractive candidate for such therapeutic strategies, as it can be engineered to exhibit high selectivity and low toxicity.

Recent advancements in synthetic methodologies have enabled the efficient preparation of 3-Dimethylaminophenylboronic acid, hydrochloride, facilitating its integration into diverse chemical processes. Researchers have demonstrated its utility in cross-coupling reactions, where it acts as a ligand or intermediate to facilitate the formation of carbon-carbon bonds. These reactions are fundamental to the synthesis of complex organic molecules, including pharmaceuticals and fine chemicals.

The pharmacological potential of 3-Dimethylaminophenylboronic acid, hydrochloride has also been explored in the context of enzyme inhibition and receptor binding studies. Its ability to interact with biological molecules makes it a valuable tool for investigating mechanisms of action and developing new therapeutic agents. For instance, studies have shown that derivatives of this compound can modulate the activity of enzymes involved in metabolic pathways relevant to diseases such as diabetes and cancer.

In addition to its pharmaceutical applications, 3-Dimethylaminophenylboronic acid, hydrochloride finds utility in materials science, particularly in the development of organic electronic materials. Boron-containing aromatic compounds often exhibit enhanced stability and electronic properties, making them suitable for use in semiconductors, conductive polymers, and other advanced materials. The dimethylamino group can further tune these properties by influencing electron delocalization and charge transport characteristics.

The synthesis of 3-Dimethylaminophenylboronic acid, hydrochloride typically involves multi-step organic transformations starting from readily available precursors. Advances in catalytic techniques have streamlined these processes, reducing reaction times and improving yields. Such improvements are crucial for scaling up production and making this compound more accessible for industrial applications.

From a regulatory perspective, 3-Dimethylaminophenylboronic acid, hydrochloride is subject to standard chemical safety protocols due to its reactivity and potential health effects. Proper handling procedures must be followed to ensure worker safety and environmental compliance. However, its classification does not place it under stringent regulatory controls related to hazardous substances or controlled drugs.

The future prospects for 3-Dimethylaminophenylboronic acid, hydrochloride are promising, with ongoing research exploring new applications and refining existing ones. As our understanding of molecular interactions deepens, this compound is expected to play an increasingly important role in drug discovery and material innovation. Collaborative efforts between academia and industry will be essential to fully realize its potential across multiple disciplines.

• 178752-79-9((3-(dimethylamino)phenyl)boronic acid)
• 1315335-14-8(2-(dimethylamino)phenylboronic acid hydrochloride)
• 201802-67-7(4-(Diphenylamino)benzeneboronic acid)
• 85006-23-1((3-aminophenyl)boronic acid;hydrochloride)
• 28611-39-4((4-(dimethylamino)phenyl)boronic acid)
• 877064-60-3(3-(methylamino)phenylboronic acid)
• 503299-18-1(Boronic acid, [6-(diphenylamino)-2-naphthalenyl]-)
• 1150114-73-0([4-(dimethylamino)phenyl]boronic acid;hydrochloride)
• 717888-41-0((4-(Naphthalen-1-yl(phenyl)-amino)phenyl)boronic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)